Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |